August 01, 2014 2:04 AM ET

Capital Markets

Company Overview of Linden LLC

Executive Profile

Richard U. De Schutter

Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Finance Committee, Incyte Corporation
AgeTotal Calculated CompensationThis person is connected to 9 Board Members in 9 different organizations across 17 different industries.

See Board Relationships
73$323,648

Background

Mr. Richard U. De Schutter has been the President of L.B. Gemini, Inc. since 2000. Mr. De Schutter served as an Operating Partner of Linden LLC. He served as Executive Chairman, Chief Executive Officer and President of DuPont Pharmaceutical Company from 2000 to December 2001. He joined DuPont Pharmaceutical Company in 2000. From January 1999 to March 2000, he served as the Chief Administration Officer of Monsanto Company, where he served for 35 years. He served as the ...

Corporate Headquarters

111 South Wacker Drive
Chicago, Illinois 60606

United States

Phone: 312-506-5600
Fax: 312-506-5601

Board Members Memberships

Prior
Former Director
Independent Director, Chairman of Nominating & Governance Committee, Member of Audit Committee and Member of Compensation Committee
Chairman, President, and Chief Executive Officer
Former Chairman and Chief Executive Officer
Former Chairman of the Board
Former Director
Director and Chairman of Organization & Compensation Committee
Director
Director
1997-2004
Former Director
1999-N/A
Former Vice Chairman, Chief Administrative Officer, Chairman of G D Searle & Co, Chief Executive Officer of G D Searle & Co and President of G D Searle & Co
1999-N/A
Former Director
2001-2014
Former Senior Independent Non-Executive Director, Member of Audit Committee, Member of Ethics & Compliance Committee and Member of Nomination & Governance Committee
2001-Present
Chairman, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Finance Committee
2001-Present
Non-Executive Director, Member of Audit Committee and Member of Remuneration Committee
2001-Present
Non-Executive Director
2002-Present
Director
2004-2010
Former Independent Director, Vice Chairman of Governance Committee and Member of Audit Committee
2012-Present
Chairman, Member of Governance & Nominating Committee and Member of Organization & Compensation Committee

Education

MS
The University of Arizona
BS
The University of Arizona
Unknown/Other Education
Columbia Business School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$126,000
Total Calculated Compensation$323,648
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Harvey J. Berger M.D.Principal Founder, Chairman, Chief Executive Officer, President and Chairman of Executive Committee
Ariad Pharmaceuticals Inc.
$749.8K
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$528.2K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$1.1M
Werner Lanthaler MBA,MPAChief Executive Officer
Evotec AG
$601.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Linden LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.